147 related articles for article (PubMed ID: 11535733)
41. Comparison of the infection imaging properties of a 99mTc labeled chemotactic peptide with 111In IgG.
Babich JW; Graham W; Barrow SA; Fischman AJ
Nucl Med Biol; 1995 Jul; 22(5):643-8. PubMed ID: 7581175
[TBL] [Abstract][Full Text] [Related]
42. Inflammation and infection imaging with a 99mTc-neutrophil elastase inhibitor in monkeys.
Rusckowski M; Qu T; Pullman J; Marcel R; Ley AC; Ladner RC; Hnatowich DJ
J Nucl Med; 2000 Feb; 41(2):363-74. PubMed ID: 10688123
[TBL] [Abstract][Full Text] [Related]
43. Bispecific monoclonal antibody-mediated targeting of an indium-111-labeled DTPA dimer to primary colorectal tumors: pharmacokinetics, biodistribution, scintigraphy and immune response.
Le Doussal JM; Chetanneau A; Gruaz-Guyon A; Martin M; Gautherot E; Lehur PA; Chatal JF; Delaage M; Barbet J
J Nucl Med; 1993 Oct; 34(10):1662-71. PubMed ID: 8410279
[TBL] [Abstract][Full Text] [Related]
44. [Biodistribution of low-molecular-weight proteins and technetium (99mTc) labeled peptides in an animal model of inflammation].
Komárek P; Kleisner I; Konopková M; Komárková I
Ceska Slov Farm; 2002 Sep; 51(5):252-6. PubMed ID: 12407925
[TBL] [Abstract][Full Text] [Related]
45. Rapid imaging of human melanoma xenografts using an scFv fragment of the human monoclonal antibody H11 labelled with 111In.
Reilly RM; Maiti PK; Kiarash R; Prashar AK; Fast DG; Entwistle J; Dan ; Narang SA; Foote S; Kaplan HA
Nucl Med Commun; 2001 May; 22(5):587-95. PubMed ID: 11388583
[TBL] [Abstract][Full Text] [Related]
46. Technetium-99m labelled hydrazinonicotinamido human non-specific polyclonal immunoglobulin G for detection of infectious foci: a comparison with two other technetium-labelled immunoglobulin preparations.
Claessens RA; Boerman OC; Koenders EB; Oyen WJ; van der Meer JW; Corstens FH
Eur J Nucl Med; 1996 Apr; 23(4):414-21. PubMed ID: 8612662
[TBL] [Abstract][Full Text] [Related]
47. Pemetrexed improves tumor selectivity of 111In-DTPA-folate in mice with folate receptor-positive ovarian cancer.
Müller C; Schibli R; Krenning EP; de Jong M
J Nucl Med; 2008 Apr; 49(4):623-9. PubMed ID: 18344429
[TBL] [Abstract][Full Text] [Related]
48. Biodistribution and kinetics of radiolabeled proteins in rats with focal infection.
Oyen WJ; Claessens RA; van der Meer JW; Corstens FH
J Nucl Med; 1992 Mar; 33(3):388-94. PubMed ID: 1740708
[TBL] [Abstract][Full Text] [Related]
49. Biodistribution of indium-111-labeled antibody directed against intercellular adhesion molecule-1.
Sasso DE; Gionfriddo MA; Thrall RS; Syrbu SI; Smilowitz HM; Weiner RE
J Nucl Med; 1996 Apr; 37(4):656-61. PubMed ID: 8691262
[TBL] [Abstract][Full Text] [Related]
50. Retention of technetium-99m in infectious foci in rats after release from technetium-99m labelled human non-specific polyclonal immunoglobulin G: a dual-label study with hydrazinonicotinamido and iminothiolano immunoglobulin.
Claessens RA; Koenders EB; Oyen WJ; Corstens FH
Eur J Nucl Med; 1996 Nov; 23(11):1536-9. PubMed ID: 8854855
[TBL] [Abstract][Full Text] [Related]
51. Pretargeted immunoscintigraphy: effect of hapten valency on murine tumor uptake.
Goodwin DA; Meares CF; McTigue M; Chaovapong W; Diamanti CI; Ransone CH; McCall MJ
J Nucl Med; 1992 Nov; 33(11):2006-13. PubMed ID: 1432163
[TBL] [Abstract][Full Text] [Related]
52. Pretargeted radioimmunoimaging with a biotinylated D-D
Hong Z; Deng S; Shi Y; Xie Y; You J; Wang W; Huang H; Liu Z
J Int Med Res; 2020 Jul; 48(7):300060520937162. PubMed ID: 32692291
[TBL] [Abstract][Full Text] [Related]
53. Detection of acute infection/inflammation with Tc-99m labeled intact polyvalent human IgG.
Wong DW; Eisenman JI; Wade W
Nucl Med Biol; 1995 May; 22(4):513-9. PubMed ID: 7550029
[TBL] [Abstract][Full Text] [Related]
54. Improved imaging of infections by avidin-induced clearance of 99mTc-biotin-PEG liposomes.
Laverman P; Zalipsky S; Oyen WJ; Dams ET; Storm G; Mullah N; Corstens FH; Boerman OC
J Nucl Med; 2000 May; 41(5):912-8. PubMed ID: 10809208
[TBL] [Abstract][Full Text] [Related]
55. 99mTc-HMPAO-labeled autologous versus heterologous leukocytes for imaging infection.
Gratz S; Rennen HJ; Boerman OC; Oyen WJ; Mast P; Behr TM; Corstens FH
J Nucl Med; 2002 Jul; 43(7):918-24. PubMed ID: 12097463
[TBL] [Abstract][Full Text] [Related]
56. Improved targeting of pancreatic cancer: experimental studies of a new bispecific antibody, pretargeting enhancement system for immunoscintigraphy.
Cardillo TM; Karacay H; Goldenberg DM; Yeldell D; Chang CH; Modrak DE; Sharkey RM; Gold DV
Clin Cancer Res; 2004 May; 10(10):3552-61. PubMed ID: 15161715
[TBL] [Abstract][Full Text] [Related]
57. D-lysine reduction of indium-111 octreotide and yttrium-90 octreotide renal uptake.
Bernard BF; Krenning EP; Breeman WA; Rolleman EJ; Bakker WH; Visser TJ; Mäcke H; de Jong M
J Nucl Med; 1997 Dec; 38(12):1929-33. PubMed ID: 9430472
[TBL] [Abstract][Full Text] [Related]
58. In vitro and in vivo effects of diethylene triamine penta-acetic acid on the distribution of indium-111 monoclonal antibody metabolism.
Kimura Y; Fujii T; Ochi K; Akamune A; Hamamoto K
Eur J Nucl Med; 1992; 19(9):759-64. PubMed ID: 1396870
[TBL] [Abstract][Full Text] [Related]
59. Technetium-99m-white blood cell-specific imaging agent developed from platelet factor 4 to detect infection.
Moyer BR; Vallabhajosula S; Lister-James J; Bush LR; Cyr JE; Snow DA; Bastidas D; Lipszyc H; Dean RT
J Nucl Med; 1996 Apr; 37(4):673-9. PubMed ID: 8691265
[TBL] [Abstract][Full Text] [Related]
60. Radiolabeling, biodistribution, and dosimetry of (123)I-mAb 14C5: a new mAb for radioimmunodetection of tumor growth and metastasis in vivo.
Lahorte CM; Bacher K; Burvenich I; Coene ED; Cuvelier C; De Potter C; Thierens H; Van de Wiele C; Dierckx RA; Slegers G
J Nucl Med; 2004 Jun; 45(6):1065-73. PubMed ID: 15181142
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
